About the Company
NeurAxis, Inc
BUSINESS DESCRIPTION
NeurAxis is a growth stage company focused on developing neuromodulation therapies to address chronic and debilitating conditions in children. NeurAxis is dedicated to advancing the science with its’ proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. We believe that superior science, evidence-based research, and building on its unparalleled body of clinical evidence is necessary for adoption by the medical...
NeurAxis, Inc News
-
NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effe...
08/27/2024 01:00 PMCARMEL, Ind., Aug. 27, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commer...
-
NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective ...
08/13/2024 01:00 PMCARMEL, Ind., Aug. 13, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commer...
-
NeurAxis Reports Second Quarter 2024 Financial Results...
08/09/2024 12:00 PMConference call will be held today, Friday, August 9 at 9:00 am ETCarmel, Ind., Aug. 09, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Comp...
-
NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday,...
08/05/2024 01:00 PMCARMEL, Ind., Aug. 05, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commer...
-
NeurAxis Submits Application to FDA to Expand IB-Stim Label...
06/07/2024 03:41 PMNeurAxis Submits Application to FDA to Expand IB-Stim Label...
-
NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim La...
06/07/2024 01:00 PMCARMEL, Ind., June 07, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commer...
-
NeurAxis Reports First Quarter 2024 Financial Results...
05/22/2024 12:00 PMCARMEL, Ind., May 22, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commerc...
-
NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference o...
05/21/2024 01:00 PMCARMEL, Ind., May 21, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commerc...
-
NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in F...
05/16/2024 01:00 PMCARMEL, Ind., May 16, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commerc...
Disclaimer: